The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
about
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki diseaseThe inflammatory protein Pentraxin 3 in cardiovascular diseaseA Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA SequencingThe Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability.Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension.Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.A RTK-based functional RNAi screen reveals determinants of PTX-3 expression.Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease.Consolidated and emerging inflammatory markers in coronary artery diseasePathogen recognition by the long pentraxin PTX3.Dexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3: potential clinical implications.Effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkersMarkers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosisInverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseExtracellular pattern recognition molecules in health and diseasesEffect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia.Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up studyRelationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.High-density lipoproteins and the immune systemLong pentraxin 3: experimental and clinical relevance in cardiovascular diseasesTREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in childrenVascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.Association of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein with the Extent of Coronary Stenosis in Patients Undergoing Coronary AngiographyCardiovascular inflammation.Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome.The clearance of cell remnants and the regeneration of the injured muscle depend on soluble pattern recognition receptor PTX3.Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling.Clinical utility of novel biomarkers for cardiovascular disease risk stratification.High density lipoproteins and atherosclerosis: emerging aspects.Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.Pentraxin 3 and lipid profile status in pregnancy.Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.Pentraxins in the activation and regulation of innate immunity.The immunology of atherosclerosis.Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity.The effects of high intensity interval training in women with rheumatic disease: a pilot study.
P2860
Q24633011-75D9D7F9-603E-452D-9465-85B999DAB101Q26738957-BADBCF23-C00D-4EC1-ACD0-0801724C7943Q28469378-6D9B3D80-E146-47AB-8EC4-459C2FEFE27DQ33632047-13D59C88-87B8-4171-9143-592034131695Q33768947-6A551E92-D592-4DF2-98E1-8C0BA97955B7Q34430183-19C1D81B-33BA-46CA-AC62-4E5C184574DBQ34534979-D6FCDACF-F245-4456-BD61-A09D37F24487Q34662196-BEF1580D-76A0-47BA-AB00-DCF87C55F39BQ34724967-EE42DFFE-0D52-4CA2-B4EC-1C62B85FC950Q35019922-B053A82E-B25F-4BA2-9380-FD70972302D7Q35054493-52FF8E95-0C63-484D-B751-D7D315A95A51Q35110197-E14F5F43-1E7E-47DF-9DAC-F9B7E6FE21E1Q35230060-0F701AEA-FAC1-4C23-AABA-E47AA4CBAC6DQ35556624-DD1DA668-A217-47AF-A0E6-77F43C743719Q35664554-5BF5C347-197F-477F-AEB1-DC43ED75B41DQ36302684-3AD7652E-27A9-4A21-B3E7-7AF73A45C511Q36430516-E541ADEC-AAA7-4536-A93C-B29B1F56E6B9Q36538797-FB3E9E21-97F2-4714-9FAA-775A28FD34B9Q36551416-B5A2C5B7-3992-4409-ACA5-A62E2B3D02F6Q36610592-CD3F2999-C919-4F31-9E12-08B98EB1B7FDQ36830914-9A95FC58-1D77-49C2-9408-A08ECBCFC12AQ36831288-EAC6263C-155C-4304-B7FA-C9B7AD5C1979Q36869842-C57F1B87-4F5B-4646-B6DD-E88054DC0D2FQ37041355-5B09B690-9111-407E-B494-73B41811676DQ37105193-71FE4CF6-8725-4182-82A7-35A756396883Q37309372-5C38B208-793C-49C6-9A2E-9F98E047AB2CQ37604058-B15B99F3-B817-4A17-9E2B-C43DF1EB7D06Q37621173-D78DA8C5-5A2F-48CD-A100-31B130F8142BQ37629231-E800F857-0ED9-46A7-89FA-FB8EF99DE878Q37660315-64458180-1C0D-4CAE-BA3C-52E4D5D8149FQ37851153-BE0B5855-BF24-4DDF-A478-8FDB367CD4D8Q38052852-4F473515-79F4-46CD-9058-5C84F794CCFDQ38076113-CA19F88F-DDBF-42CD-99DC-F863C6905E32Q38084920-2EAF28BB-B2B6-4CAD-BE47-4A528083B12CQ38728491-3AA921B7-5137-4BCC-8372-6A83F7BA640EQ38734509-8309E31A-5A80-4345-AD14-1D9802B9A1B7Q38991073-3500B5DC-8FA3-4841-AF3E-7F572054FC55Q39230390-A2436D47-A9A3-4142-AD48-6A562DF247DAQ39477901-522E3AAF-038B-43E3-AA34-642E3E294ECBQ40900237-70E28A78-01A2-408C-8D51-1A386C769901
P2860
The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@en
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@nl
type
label
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@en
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@nl
prefLabel
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@en
The long pentraxin PTX3: a mod ...... s and cardiovascular diseases.
@nl
P50
P1476
The long pentraxin PTX3: a mod ...... is and cardiovascular diseases
@en
P356
10.1016/J.TCM.2010.03.005
P577
2010-02-01T00:00:00Z